Evidence map›Paper›PMID 25560296›Full record

ArticleBiochimica et biophysica acta2015

Molecular basis of E. coli L-threonine aldolase catalytic inactivation at low pH.

Soumya G Remesh, Mohini S Ghatge, Mostafa H Ahmed, Faik N Musayev, Amit Gandhi, Nadia Chowdhury, Martino L di Salvo, Glen E Kellogg, Roberto Contestabile, Verne Schirch and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Soumya G RemeshDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, VA, USA.
Mohini S GhatgeDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, VA, USA.
Mostafa H AhmedDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, VA, USA.
Faik N MusayevDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, VA, USA.
Amit GandhiDivision of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
Nadia ChowdhuryDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, VA, USA.
Martino L di SalvoDipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Via degli Apuli 9, 00185 Roma, Italy.
Glen E KelloggDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, VA, USA.
Roberto ContestabileDipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Via degli Apuli 9, 00185 Roma, Italy.
Verne SchirchDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, VA, USA.
Martin K SafoDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: msafo@vcu.edu.
Virginia Commonwealth University · USSapienza University of Rome · ITBrigham and Women's Hospital · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Paula Daniela Bos · 1985 to 2026
$51.0M
NCI NIH HHS CA 16059-28NCI NIH HHS P30 CA016059
6 · The paper itself

Abstract

L-Threonine aldolases (TAs), a family of enzymes belonging to the fold-type I pyridoxal 5'-phosphate (PLP) dependent enzymes, play a role in catalyzing the reversible cleavage of l-3-hydroxy-α-amino acids to glycine and the corresponding aldehydes. Threonine aldolases have great biotechnological potential for the syntheses of pharmaceutically relevant drug molecules because of their stereospecificity. The pH-dependency of their catalytic activity, affecting reaction intermediates, led us to study the effect of low-pH on Escherichia coli TA (eTA) structure. We report here a low-pH crystal structure of eTA at 2.1 Å resolution, with a non-covalently bound uncleaved l-serine substrate, and a PLP cofactor bound as an internal aldimine. This structure contrasts with other eTA structures obtained at physiological pH that show products or substrates bound as PLP-external aldimines. The non-productive binding at low-pH is due to an unusual substrate serine binding orientation in which the α-amino group and carboxylate group are in the wrong positions (relative to the active site residues) as a result of protonation of the α-amino group of the serine, as well as the active site histidines, His83 and His126. Protonation of these residues prevents the characteristic nucleophilic attack of the α-amino group of substrate serine on C4' of PLP to form the external aldimine. Our study shows that at low pH the change in charge distribution at the active site can result in substrates binding in a non-productive orientation.

Indexed as

CatalysisCatalytic DomainCrystallography, X-RayEnzyme ActivationEscherichia coliGlycine HydroxymethyltransferaseHydrogen-Ion ConcentrationKineticsModels, MolecularProtein BindingPyridoxal PhosphateSerineThreonineGlycine HydroxymethyltransferasePyridoxal PhosphateSerineThreonineInternal aldiminePLP-dependent enzymesProtein crystallographyPyridoxal 5′-phosphateThreonine aldolaseTransaldimination

Identifiers

PMID25560296
PMCPMC4323617
OpenAlexW2002381976

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.